Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.
Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.
复制标题
硫利达嗪治疗可预防克氏锥虫感染小鼠的心脏病。
DOI:
10.1016/j.ijantimicag.2003.10.006
复制
发表时间:
2004
影响因子:
10.8
通讯作者:
P. Paglini
中科院分区:
文献类型:
--
作者:
M. Presti;H. Rivarola;J. Bustamante;A. R. Fernández;J. Enders;R. Fretes;S. Gea;P. Paglini
Trypanosoma cruzi trypanothione reductase is an enzyme that has been identified as a potential target for chemotherapy. Thioridazine inhibits it and prevented cardiopathy in mice infected with T. cruzi Tulahuen strain. As not all T. cruzi strains respond to treatment in the same way, an isolate from a chronic patient (SGO Z12) was used; parasitaemias were studied along with, survival, serology, electrocardiography, histology and cardiac β receptor function. Parasitaemia in thioridazine (80mg/(kgday) for 3 days) treated mice was less and lasted for a shorter period (P<0.01), there were reduced electrocardiographic and histological alterations and significantly improved survival (80% of non-treated died). Treated mice had lower receptor affinity and higher density as a compensatory mechanism, modifying the course of T. cruzi infection (SGO Z12 isolate) and preventing the consequent cardiopathy.